Elsevier

Clinical Radiology

Volume 56, Issue 9, September 2001, Pages 714-725
Clinical Radiology

Pictorial Review
MRI Contrast Agents for Evaluating Focal Hepatic Lesions

https://doi.org/10.1053/crad.2001.0764Get rights and content

Abstract

Contrast-enhanced magnetic resonance imaging (MRI) has become an important tool in the detection and characterization of focal hepatic lesions especially when other investigations such as ultrasound (US) and computed tomography (CT) are inconclusive. The purpose of this pictorial review is to briefly summarize the properties of various MRI contrast agents used in hepatic imaging and to highlight their role in evaluation of focal hepatic lesions.Harisinghani, M. G. et al. (2001). Clinical Radiology56, 714–725.

References (37)

  • AE Mahfouz et al.

    Contrast agents for MR imaging of the liver: a clinical overview

    Eur Radiol

    (1997)
  • RN Low

    Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver

    Top Magn Reson Imaging

    (1998)
  • SA Mirowitz et al.

    Dynamic gadolinium-enhanced rapid acquisition spin-echo MR imaging of the liver

    Radiology

    (1991)
  • Y Yamashita et al.

    Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver

    Radiology

    (1996)
  • MJ Lee et al.

    Focal nodular hyperplasia of the liver: MR findings in 35 proved cases

    Am J Roentgenol

    (1991)
  • P Soyer et al.

    Focal nodular hyperplasia of the liver: assessment of hemodynamic and angioarchitectural patterns with gadolinium chelate- enhanced 3D spoiled gradient-recalled MRI and maximum intensity projection reformatted images

    J Comput Assist Tomogr

    (1996)
  • KY Chung et al.

    Hepatocellular adenoma: MR imaging features with pathologic correlation

    Am J Roentgenol

    (1995)
  • T Murakami et al.

    Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT

    Acta Radiol

    (1995)
  • Cited by (29)

    • Liver: Normal Anatomy and Examination Techniques

      2014, Textbook of Gastrointestinal Radiology: Volumes 1-2, Fourth Edition
    • Nanoparticles for improving cancer diagnosis

      2013, Materials Science and Engineering R: Reports
      Citation Excerpt :

      They are usually polymers such as polyvinylpyrrolidone (PVP), dendrimers, polyaniline, and dextrans [87–93] which lower the surface energy and increase electrostatic repulsion, resulting in improved colloidal stability. Most IONPs used clinically, including Feridex, Combidex, Resovist, and Ferumoxytol, are made by the co-precipitation method using dextran and its derivatives as the coating materials [94,95]. A sugar coating does not favor direct bio-molecule coupling, and to make the particles conjugation-friendly, a post-synthesis surface engineering step is usually required.

    • Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles

      2012, Methods in Enzymology
      Citation Excerpt :

      These nanoagents are expected to modulate the pharmacokinetics and biodistribution of the PA, potentially increasing the efficacy of therapy. Dextran-coated monocrystalline iron oxide nanoparticles (MION) have been used clinically for almost two decades and have found utility in the detection of metastases (Harisinghani et al., 2001; Saini et al., 2000), the imaging of angiogenesis (Tang et al., 2005), the examination of primary tumors (Enochs et al., 1999), and the detection of atherosclerotic lesions (Kooi et al., 2003). Their usefulness is a result of their innate localization to inflammatory sites and uptake by phagocytic cells, such as macrophages.

    • Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes

      2010, Biomaterials
      Citation Excerpt :

      They have no tissue specificity and are excreted through the kidneys. More recently, agents have been introduced that possess longer residence times, mainly because they are recruited intracellularly, and therefore allow extended imaging procedures [6]. Nanosized superparamagnetic iron oxide contrast agents, also called SPIO (“small particle iron oxides” or “superparamagnetic iron oxides”), remain in the circulation for extended periods of time depending on particle size and surface coating.

    • Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair

      2008, Biomaterials
      Citation Excerpt :

      SPIO particles are biocompatible because of their biodegradable iron oxide core and their appropriate surface coating, which allows intracellular incorporation [4]. SPIO-based imaging of macrophage activity was the initial and is still the most significant clinical application in this field, in particular for tumour staging of the liver and lymph nodes [6,7]. As a valuable tool in preclinical research, various non-phagocytic cells, including MSCs, were previously labelled in culture with SPIO particles [8–13].

    View all citing articles on Scopus
    f1

    Author for correspondence and guarantor of study: Dr Mukesh G. Harisinghani, Division of Abdominal and Interventional Radiology, White 270, Massachusetts General Hospital, Boston, MA 02114, U.S.A. Fax: +1 617 726 4891; E-mail: [email protected]

    View full text